1. Home
  2. DSWL vs ALXO Comparison

DSWL vs ALXO Comparison

Compare DSWL & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Deswell Industries Inc.

DSWL

Deswell Industries Inc.

N/A

Current Price

$3.30

Market Cap

56.7M

Sector

Industrials

ML Signal

N/A

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

N/A

Current Price

$2.14

Market Cap

68.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DSWL
ALXO
Founded
1987
2015
Country
Macau
United States
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.7M
68.3M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
DSWL
ALXO
Price
$3.30
$2.14
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$3.42
AVG Volume (30 Days)
9.1K
872.5K
Earning Date
01-01-0001
06-01-2026
Dividend Yield
6.02%
N/A
EPS Growth
N/A
31.02
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$0.41
52 Week High
$4.48
$2.66

Technical Indicators

Market Signals
Indicator
DSWL
ALXO
Relative Strength Index (RSI) 37.45 51.04
Support Level $3.27 $2.01
Resistance Level $3.38 $2.27
Average True Range (ATR) 0.13 0.23
MACD -0.05 -0.06
Stochastic Oscillator 0.00 19.23

Price Performance

Historical Comparison
DSWL
ALXO

About DSWL Deswell Industries Inc.

Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: